Molybdenum Cofactor Deficiency with Cerebral Atrophy

نویسندگان

چکیده

Case presentation: Full term newborn, Apgar 9/9, with no family history of neurological diseases, developed breathing and feeding difficulties, reason why was admitted at the hospital on her 7th life day. On examination, presented craniofacial dysmorphic features, anisocoria reactive to light, absence blink reflex, divergent strabismus discreet skew deviation, hypertonia limbs clonic movements, rough skin diffuse maculopapular lesions, furfuraceous scaling. The patient hospitalized stabilized in UCI, needing OTI. In first investigation, infectious triage cerebral USG were normal. MRI 9th day evidenced edema, bilateral injury thalamus a high lactate spectroscopy. progressed seizures crisis difficult control, due that, hypoproteic diet initiated, good response. treatable diseases panel showed variants that isolated would justify clinical picture. A complete sequencing genome revealed variant c.377+1G>A, p.(?) intronic region succeeds exon 5 MOCS2 gene, homozygous, diagnosing molybdenum cofactor deficiency B. month plenty areas cystic degeneration, important volumetric encephalic reduction N-acetylaspartate peak. Nowadays she's home, being treated Phenobarbital, Levetiracetam, Oxcarbazepine, L-carnitine, Pyridoxine Clonazepam.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Child Neurology: Molybdenum cofactor deficiency.

Molybdenum cofactor deficiency (MoCD) is a rare inherited metabolic disorder characterized by neonatal onset intractable seizures, severe psychomotor retardation, dysmorphic facies, and dislocated ocular lenses. A characteristic biochemical profile permits early diagnosis. Although more than 100 genetically characterized patients have been reported, this number is discrepant with the actual pre...

متن کامل

Molybdenum Cofactor and Sulfite Oxidase Deficiency

A universal molybdenum-containing cofactor is necessary for the activity of all eukaryotic molybdoenzymes. In humans four such enzymes are known: Sulfite oxidase, xanthine oxidoreductase, aldehyde oxidase and a mitochondrial amidoxime reducing component. Of these, sulfite oxidase is the most important and clinically relevant one. Mutations in the genes MOCS1, MOCS2 or GPHN all encoding cofactor...

متن کامل

Molybdenum Cofactor Biology and Disorders Related to Its Deficiency; A Review Study

Background: Molybden, as a vital and essential micronutrient is directly involved in the metabolism of other elements including carbon, sulfur, and nitrogen. Molybdenum alone is not biologically active unless it binds to specific cofactors. Except for the bacterial nitrogenase, which contains molybdenum-Iron complex, molybdenum cofactor (Moco) is considered as the bioactive component placed in ...

متن کامل

Clinical neuroimaging features and outcome in molybdenum cofactor deficiency.

Molybdenum cofactor deficiency predominantly affects the central nervous system. There are limited data on long-term outcome or brain magnetic resonance imaging (MRI) features. We examined the clinical, brain MRI, biochemical, genetic, and electroencephalographic features and outcome in 8 children with a diagnosis of molybdenum cofactor deficiency observed in our institution over 10 years. Two ...

متن کامل

Choice of anesthesia in molybdenum cofactor deficiency: A case report

Molybdenum cofactor (MC) deficiency is defined as a progressive neurodegenerative and neurometabolic disease, characterized by convulsions, severe mental and motor retardation resistant to the treatment. Patients with MC deficiency usually need at least sedation for even minor interventions such as dental examination or treatment. Sedation or general anesthesia for these patients may be complic...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Arquivos De Neuro-psiquiatria

سال: 2023

ISSN: ['1678-4227', '0004-282X']

DOI: https://doi.org/10.1055/s-0043-1774556